Press release
Inactivated Influenza Vaccine Market Report Examines Leading Companies And Growth Opportunities
Inactivated Influenza Vaccine Market
Projected Market Growth of the Inactivated Influenza Vaccine Market by 2030
The inactivated influenza vaccine market is forecasted to grow robustly, reaching a valuation of $10.55 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 8.1% during the forecast period. The upward trend is fueled by several factors, including greater emphasis on pandemic preparedness, increased investments in cell-based and recombinant vaccine technologies, and the expansion of immunization programs targeting adults and elderly populations. Additionally, growing government procurement efforts and advancements in vaccine manufacturing methods are playing a crucial role. Key trends shaping the market include wider adoption of quadrivalent vaccines, heightened focus on high-dose and adjuvanted variants, growth in seasonal vaccination initiatives, improvements in cold-chain logistics, and an enhanced focus on scalable vaccine production.
Download a free sample of the inactivated influenza vaccine market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24251&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Leading Participants in the Inactivated Influenza Vaccine Market
The industry features several prominent companies actively shaping the market landscape. These include Sanofi S.A., GlaxoSmithKline plc, CSL Limited, Viatris Inc., Zydus Lifesciences Limited, Sinovac Biotech Ltd., Bharat Biotech International Limited, Hualan Biological Bacterin Co. Ltd., Changchun Biological Products Co. Ltd., Dalian Aleph Biomedical Co. Ltd., Jiangsu GDK Biotechnology Co. Ltd., KM Biologics Co. Ltd., JoinHub Pharma, Seqirus (CSL Influenza Division), Serum Institute of India Pvt. Ltd., Biological E. Limited, Shenzhen Sanofi Pasteur Biologicals Co. Ltd., Beijing Tiantan Biological Products Co. Ltd., Wuhan Institute of Biological Products Co. Ltd., Lanzhou Institute of Biological Products Co. Ltd., Chengdu Institute of Biological Products Co. Ltd., Sinopharm CNBG, Takeda Pharmaceutical Company Limited, and Pfizer.
In a significant development in July 2024, UK-based pharmaceutical giant GSK plc acquired full rights from CureVac N.V. to develop, manufacture, and commercialize mRNA-based influenza and COVID-19 vaccines. This strategic move is expected to accelerate GSK's mRNA vaccine programs by leveraging CureVac's expertise and technologies. CureVac, headquartered in Germany, specializes in mRNA therapeutics, including vaccines aimed at influenza and cancer immunotherapy.
View the full inactivated influenza vaccine market report:
https://www.thebusinessresearchcompany.com/report/inactivated-influenza-vaccine-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Emerging Trends in the Inactivated Influenza Vaccine Market
Industry players are increasingly focusing on the development of quadrivalent inactivated influenza vaccines that provide protection against four distinct influenza virus strains. These vaccines aim to offer broader and more effective coverage compared to earlier versions. For instance, in February 2025, India-based Zydus Lifesciences introduced VaxiFlu-4, a quadrivalent inactivated influenza vaccine designed to protect against four seasonal virus strains. This vaccine offers enhanced protection against both influenza A and B viruses, reducing the chances of vaccine mismatch and strengthening immune defense based on regional flu patterns.
The emerging focus on quadrivalent vaccines underscores a broader market trend toward improving vaccine efficacy and tailoring immunization programs to better meet seasonal and geographical needs. This shift is expected to drive further innovations and adoption of these more comprehensive vaccines globally.
Market Segmentation and Dominant Share in the Inactivated Influenza Vaccine Market
This report categorizes the inactivated influenza vaccine market into several key segments:
1) Vaccine Type: Trivalent Inactivated Influenza Vaccine (TIIV) and Quadrivalent Inactivated Influenza Vaccine (QIIV)
2) Application: Children, Adolescents, Adults, and Elderly
3) Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Public Health Clinics
4) End-User: Healthcare Providers, Individuals, Government Organizations, and Pharmaceutical Companies
Further subsegments within vaccine types are also defined:
- For Trivalent Inactivated Influenza Vaccine (TIIV): Egg-based, Cell-based, Adjuvanted, and High-dose versions.
- For Quadrivalent Inactivated Influenza Vaccine (QIIV): Egg-based, Cell-based, Adjuvanted, Recombinant, and Pediatric formulations.
These classifications help to understand the diverse product offerings and application areas that shape the market's growth and demand patterns.
Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Inactivated Influenza Vaccine Market Report Examines Leading Companies And Growth Opportunities here
News-ID: 4571423 • Views: …
More Releases from The Business Research Company
Intracranial Stents Market Demonstrates Long-Term Growth Potential At 15.6% CAGR
The intracranial stents market is positioned for significant expansion over the coming years, driven by advances in neurovascular treatment options and growing clinical demand. As medical technology evolves, the sector is set to experience considerable growth, fueled by innovations and increasing focus on stroke and aneurysm care. Let us explore the market size projections, the main players, emerging trends, and the key segments shaping this industry.
Rapid Growth Trajectory of the…
Interventional Tumor Ablation Market Outlook Signals Expansion To $2.66 Billion …
The interventional tumor ablation market is positioned for significant growth in the coming years, driven by technological advancements and evolving cancer treatment approaches. This sector is witnessing an increased focus on precision therapies and minimally invasive techniques, which are reshaping how tumors are treated worldwide. Let's explore the market's size projections, key players, emerging trends, and the main segments that define this industry.
Projected Growth and Market Size of the Interventional…
Interventional Neurology Devices And Equipment Market Report 2026 Market Outlook …
The interventional neurology devices and equipment sector is positioned for substantial expansion over the coming years, driven by key technological advances and increasing clinical demands. As medical providers enhance stroke and neurovascular care, this market is becoming increasingly vital. Let's explore the current market valuation, key players, future trends, and the principal segments shaping the industry's trajectory.
Market Size and Growth Outlook for Interventional Neurology Devices and Equipment
The market…
Internal Neuromodulation Devices Market Insights Highlight Segment Expansion And …
The internal neuromodulation devices market is set to experience significant expansion over the coming years, driven by advances in technology and growing demand for personalized treatment options. As healthcare providers and patients increasingly embrace innovative neuromodulation therapies, this sector is positioned for remarkable growth and transformation. Let's explore the market's size projections, key players, emerging trends, and the main segments shaping its evolution.
Projected Market Size and Growth Rate of Internal…
More Releases for Influenza
Multivalent Influenza Vaccines Market Advancing Influenza Prevention Strategies …
The "Multivalent Influenza Vaccines Market" research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Multivalent Influenza Vaccines industry along with various other factors over the predicted period 2024-2030. The report on the Multivalent Influenza Vaccines market is focusing on a series of parameters including top manufacturing strategies, industry share, prime opportunities, industrial channels, profit margin, etc.…
Influenza Diagnostics Market - Rapid Detection, Effective Protection: Influenza …
Newark, New Castle, USA: The "Influenza Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Influenza Diagnostics Market: https://www.growthplusreports.com/report/influenza-diagnostics-market/8780
This latest report researches the industry structure, sales, revenue,…
Influenza Medication Market - Fight off the influenza virus with effective and r …
Newark, New Castle, USA: The "Influenza Medication Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Influenza Medication Market: https://www.growthplusreports.com/report/influenza-medication-market/7859
This latest report researches the industry structure, sales, revenue,…
Influenza Medication Market - Revolutionizing Flu Treatment: Innovating Advanced …
Newark, New Castle, USA - new report, titled Influenza Medication Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Medication market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Medication market. The report offers an overview of the market, which…
Influenza Vaccines Market - Empowering Strength, Nurturing Immunity: Innovating …
Newark, New Castle, USA - new report, titled Influenza Vaccines Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Vaccines market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Vaccines market. The report offers an overview of the market, which…
H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del …
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,…
